P/0273/2022 : EMA on the granting of a product specific waiver for tramadol (hydrochloride) / magnesium lactate dihydrate (EMEA-003216-PIP01-22)
Key facts
| Active substance |
Magnesium lactate dihydrate Tramadol (hydrochloride)
|
| Therapeutic area |
Other
|
| Decision number |
P/0273/2022
|
| PIP number |
P/0273/2022 : EMA on the granting of a product specific waiver for tramadol (hydrochloride) / magnesium lactate dihydrate (EMEA-003216-PIP01-22)
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Treatment of pain
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Orphinic Scientific Bis Sp. z o.o.
Email: office@orphinic.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|